Enhanced Immunotherapy by Combining a Vaccine With a Novel Murine GITR Ligand Fusion Protein

Oncotarget- United States

doi 10.18632/oncotarget.20703

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Impact Journals, LLC

Related search

P28-Fur-Grb, a Novel Fusion Protein With Enhanced Targeted Cytotoxicity Against Breast Cancer

Clinical Oncology and Research
2019English

1.8 Å Structure of Murine GITR Ligand Dimer Expressed inDrosophila melanogasterS2 Cells

Acta Crystallographica Section D Biological Crystallography
2009Norwegian

A Novel Murine Cytomegalovirus Vaccine Vector Protects againstMycobacterium Tuberculosis

Journal of Immunology
AllergyImmunology
2014English

Enhanced Protection Against Malaria by a Chimeric Merozoite Surface Protein Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Eps8 Vaccine Exerts Prophylactic Antitumor Effects in a Murine Model: A Novel Vaccine for Breast Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2013English

Melittin-Mil-2 Fusion Protein as a Candidate for Cancer Immunotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

A Novel IL-10-Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand

Journal of Immunology
AllergyImmunology
2012English

Immunogenicity and Protective Efficacy Against Murine Tuberculosis of a Prime-Boost Regimen With BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Clinical and Developmental Immunology
2011English

GITR Agonism Overcomes Resistance to Immunotherapy in Solid Tumors

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy